...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

I agree 100% Jupiter. So far it has only been big talk with no convincing data to back it up for both the effect of apabetalone to module ACE2 and to disrupt interactions between virus and BET protein and/or histones. 

BDAZ

Share
New Message
Please login to post a reply